Masimo Announces FDA Clearance and Full Market Release of Rad-97™ Pulse CO-Oximeter® | Business Wire
IRVINE, Calif.-- (BUSINESS WIRE)-- Masimo (NASDAQ:MASI) announced today FDA 510 (k) clearance and full market release of Rad-97™ Pulse CO-Oximeter ®, including configurations with integrated NomoLine™ ...
After becoming the first patient monitoring company to integrate Masimo noninvasive, continuous rainbow SET® technologies, including total hemoglobin (SpHb®), in its patient monitors, Dräger will add ...
Amsterdam, the Netherlands and Irvine California – Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG; AEX: PHIA), both global leaders in patient monitoring, announced today that they have reinforced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback